Rare diseases
Investigational molecules
Locations
Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
SpainStudy of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer
SpainStudy on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma
SpainStudy of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
SpainStudy on the Effectiveness and Safety of Crovalimab for Children with Atypical Hemolytic Uremic Syndrome (aHUS)
SpainStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
SpainStudy on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
SpainStudy on MK-6194 for Adults with Systemic Lupus Erythematosus
SpainStudy on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency
SpainStudy Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment
SpainStudy on the Safety and Effectiveness of Vepdegestrant and Samuraciclib for Adults with ER+ Advanced or Metastatic Breast Cancer
SpainStudy on the Effectiveness and Safety of Osimertinib for Patients with EGFR Mutation-Positive Stage II-IIIB Non-Small Cell Lung Cancer After Tumor Removal
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
